How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Consultation on new and updated NICE indicators: GID-IND10330 to GID-IND10335 & GID-IND10337 to GID-IND10338

    Closed for comments This consultation ended on at   Request commenting lead permission

    Weight management: BMI recording (long term conditions)

    GID-IND10326: The percentage of patients with coronary heart disease, stroke or TIA, diabetes, at high risk of developing type 2 diabetes, hypertension, peripheral arterial disease, heart failure, COPD, rheumatoid arthritis, dyslipidaemia, learning disability, obstructive sleep apnoea, polycystic ovary syndrome, schizophrenia, bipolar disorder or other psychoses who have had a BMI recorded in the preceding 12 months.

    Please note that this indicator is a proposed update to existing indicator IND151 and includes a wider list of long-term conditions for which patients may benefit from annual BMI monitoring.

    Indicator type

    General practice indicator suitable for use in the QOF.

    Rationale

    The purpose of this indicator is to support regular weight measurement in adults with long-term conditions enabling potential definition of overweight, obesity and central adiposity, identification of changes in weight and central adiposity, and help in assessment and management of a long-term condition.

    Recording of weight is not current routine activity in UK primary care, it is recorded for around 30% of all patients each year (Nicholson et al. 2022). Data for patients with GP recorded CVD or CVD risk factors, indicates that about 63% have a BMI record in the last 12 months (CVDPREVENT, 2025)

    Routine consultations for managing long-term conditions are an opportunity to record a person's BMI.

    Source guidance

    NICE's guideline on overweight and obesity management (2025) recommendations 1.9.3, 1.9.7, 1.9.10 and 1.9.11

    Specification

    Numerator: The number of patients in the denominator who have had a BMI recorded in the preceding 12 months.

    Denominator: The number of patients with coronary heart disease, stroke or TIA, diabetes, at high risk of developing type 2 diabetes, hypertension, peripheral arterial disease, heart failure, COPD, rheumatoid arthritis, dyslipidaemia, learning disability, obstructive sleep apnoea, polycystic ovary syndrome, schizophrenia, bipolar disorder or other psychoses.

    Definition: A high risk of developing type 2 diabetes is a high risk score and a fasting plasma glucose of 5.5 to 6.9 mmol/L, or HbA1c of 42 to 47 mmol/mol.

    Exclusions: People aged under 18

    Personalised care adjustments or exception reporting should be considered to account for situations where the patient declines, does not attend or a BMI measurement is not appropriate.

    Question for consultation:

    16. Do you agree with the addition of the following long-term conditions to the existing indicator IND151:

    • high risk of developing type 2 diabetes

    • dyslipidaemia

    • learning disability

    • obstructive sleep apnoea

    • polycystic ovary syndrome

    • schizophrenia, bipolar disorder or other psychoses.